Health
Cannabis and Cocaine Lead EU Drug Use, But Synthetic Drugs Pose Growing Risks
Cannabis and cocaine remain the most commonly used drugs in the European Union (EU), but emerging synthetic substances are raising new public health concerns, according to a recent report by the European Commission and the Organisation for Economic Co-operation and Development (OECD).
Drug Use Patterns Across the EU
The report highlights that nearly one in three Europeans has tried illegal drugs at some point, with 15% of young adults using cannabis and 2.5% using cocaine in 2024. However, drug consumption patterns vary significantly between countries.
- Cannabis use is highest in the Czech Republic, Italy, France, and Spain, while the lowest rates are found in Malta, Turkey, and Hungary.
- Cocaine use is most prevalent in the Netherlands, Spain, and Ireland, but significantly lower in Turkey, Portugal, Poland, and Hungary.
Despite variations in drug policies across Europe, experts say tougher laws do not necessarily impact drug availability, especially among young people.
“The major penalties impact only the people who use the substance once or fewer times in a year, so not the real [heavy] users,” said Sabrina Molinaro, an epidemiologist at Italy’s National Research Council and coordinator of the European School Survey Project on Alcohol and Other Drugs.
Her research has monitored 16-year-olds’ drug use in Europe since the 1990s, revealing consistent generational trends. Notably, while teenage boys historically used cannabis more than girls, that gender gap is narrowing, and in some countries, girls now surpass boys in cannabis use.
The Rise of Synthetic and Harder Drugs
While cannabis and cocaine remain the dominant substances, other illegal drugs—such as MDMA (ecstasy), heroin, opioids, psychedelics, and synthetic drugs—are posing increasing threats.
Synthetic drugs, including lab-made cannabinoids and stimulants, are particularly concerning due to their unpredictable chemical makeup and low-quality production conditions.
“They are so dangerous because you don’t know what you are taking,” Molinaro warned, adding that some synthetic drugs are produced in poorly regulated labs, leading to potential contamination.
The EU Drugs Agency (EUDA) reported that in 2022, authorities dismantled hundreds of synthetic drug labs across the continent. The following year, seven new synthetic opioid substances—known for their high potency—were detected through the agency’s early warning system.
Health Risks and Policy Challenges
Regular drug use in the EU is associated with cardiovascular diseases, mental health issues, accidents, and infectious diseases like HIV, particularly among people using injectable substances.
Molinaro stressed that the rising presence of synthetic opioids poses serious health risks to the adult population. Given their potency, even small doses can be lethal, increasing the urgency for rapid detection and intervention.
As Europe faces an influx of new and harder-to-regulate drugs, public health experts warn that governments must adapt quickly to prevent widespread harm.
Would you like any additional details or modifications?
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
